Sign In
Buy PCRX
$22.32
+0.0700 (+0.315%)
At Close: Jun 03, 2026
Pacira (PCRX) to Report Q1 Results: Wall Street Expects Earnings Growth
12:00am, Thursday, 30'th Apr 2020How Much Did Pacira BioSciences, Inc.’s (NASDAQ:PCRX) CEO Pocket Last Year?
02:26pm, Wednesday, 29'th Apr 2020
Dave Stack has been the CEO of Pacira BioSciences, Inc. (NASDAQ:PCRX) since 2007. This report will, first, examine the...
Pacira Biosciences' (PCRX) "Buy" Rating Reiterated at Wedbush
07:08am, Tuesday, 28'th Apr 2020
Pacira Biosciences (NASDAQ:PCRX)‘s stock had its “buy” rating reissued by research analysts at Wedbush in a note issued to investors on Monday, TipRanks reports. They presently have a $85.00 tar
Pacira Pharmaceuticals (PCRX) Gets a Buy Rating from Wedbush
06:10pm, Monday, 27'th Apr 2020
Wedbush analyst Liana Moussatos reiterated a Buy rating on Pacira Pharmaceuticals (PCRX) today and set a price target of $85.00. The company's shares
Pfizer (PFE) Receives a Buy from RBC Capital
10:23am, Monday, 27'th Apr 2020
In a report released today, Randall Stanicky from RBC Capital maintained a Buy rating on Pfizer (PFE), with a price target of $44.00. The company's shares
Pfizer (PFE) Receives a Buy from RBC Capital
10:23am, Monday, 27'th Apr 2020
In a report released today,
Randall Stanicky
from RBC Capital maintained a
Buy
rating on Pfizer (
PFE
–
Research Report
), with a price target of
$44.00
. The company’s shares closed last Friday a
Perrigo Company (PRGO) Receives a Buy from RBC Capital
10:23am, Monday, 27'th Apr 2020
RBC Capital analyst Randall Stanicky maintained a Buy rating on Perrigo Company (PRGO) yesterday and set a price target of $58.00. The company's shares
Financial Counselors Inc. Buys 2,160 Shares of Pacira Biosciences Inc (NASDAQ:PCRX)
09:56am, Monday, 27'th Apr 2020
Financial Counselors Inc. boosted its stake in Pacira Biosciences Inc (NASDAQ:PCRX) by 43.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange C
Stifel Nicolaus Remains a Buy on Principia Biopharma (PRNB)
08:07am, Monday, 27'th Apr 2020
In a report issued on April 23, Derek Archila from Stifel Nicolaus reiterated a Buy rating on Principia Biopharma (PRNB). The company's shares closed last
Stifel Nicolaus Remains a Buy on Principia Biopharma (PRNB)
08:07am, Monday, 27'th Apr 2020
In a report issued on April 23, Derek Archila from Stifel Nicolaus reiterated a Buy rating on Principia Biopharma (PRNB
Analysts Offer Insights on Healthcare Companies: PTC Therapeutics (PTCT), AbbVie (ABBV) and Sanofi (OtherSNYNF)
02:43am, Monday, 27'th Apr 2020
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on PTC Therapeutics (PTCT), AbbVie (ABBV) and Sanofi
Stocks Showing Improved Relative Strength: Pacira Pharmaceuticals
12:00am, Friday, 24'th Apr 2020Analysts' Top Healthcare Picks: Eagle Pharmaceuticals (EGRX), Biogen (BIIB)
02:41pm, Thursday, 23'rd Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Eagle Pharmaceuticals (EGRX) and Biogen (BIIB) with bullish
Why Pacira BioSciences, Inc.'s (NASDAQ:PCRX) CEO Pay Matters To You
12:59pm, Thursday, 23'rd Apr 2020
In 2007, Dave Stack was appointed CEO of Pacira BioSciences, Inc. (NASDAQ:PCRX). This report will, first, examine the...
Stock Traders Purchase High Volume of Call Options on Pacira Biosciences (NASDAQ:PCRX)
07:52am, Thursday, 23'rd Apr 2020
Pacira Biosciences Inc (NASDAQ:PCRX) was the target of some unusual options trading activity on Tuesday. Stock investors purchased 606 call options on the company. This represents an increase of appro
